DrugDashboards

Imatinib

Imatinib · IMATINIB MESYLATE 100 mg/1 · Tablet · Oral · Dr.Reddy's Laboratories Inc

NDC 43598-0344-10 · 1000 TABLET in 1 CONTAINER · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for imatinib (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA206547
TE code
AB
Approval date
Aug 13, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedFeb 17, 2021
    Dr. Reddy's Laboratories, Inc.Failed Dissolution Specifications

Manufacturers of Imatinib (Tablet)

LabelerStrengthFirst seenLast seen
Dr.Reddy's Laboratories IncIMATINIB MESYLATE 100 mg/1Jul 15, 2026Sep 2, 2026
Dr.Reddy's Laboratories IncIMATINIB MESYLATE 400 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Imatinib — NDC 43598-0344-10," retrieved September 3, 2026, https://drugdashboards.com/drug/43598034410.

Free to cite with attribution — see how the data is put together.